Detection of CXADR protein for diagnosis of kidney cancer
US7998689B2 · kind B2 · utility
13Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2009 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Sep 10, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.